
RIVAWAR: Rivaroxaban Akin to Warfarin for Left Ventricular Thrombus After MI
Rivaroxaban achieved comparable efficacy and safety to warfarin in resolving left ventricular blood clots in patients hospitalized with myocardial infarction (MI) without displaying evidence of excess harm, including mortality and bleeding risks.1 The open …